60 Day Federal Registry Notice

58865

Federal Register / Vol. 71, No. 193 / Thursday, October 5, 2006 / Notices
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.

VI. Approval of Budget for FY 2007.
VII. Old Business.
VIII. New Business.
IX. Adjournment.
Frederick G. Slabach,
Executive Secretary.
[FR Doc. 06–8526 Filed 10–3–06; 9:49 am]
BILLING CODE 6820–AD–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention

Proposed Project

[60 Day–06–0425X]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have

The National Centers for Autism and
Developmental Disabilities Research
and Epidemiology (CADDRE) Study—
New—National Center on Birth Defects
and Developmental Disabilities
(NCBDDD), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Children’s Health Act of 2000
mandated CDC to establish autism
surveillance and research programs to
address the number, incidence,
correlates, and causes of autism and
related disabilities. Under the
provisions of this act, CDC funded 5
CADDRE centers including the
California Department of Health and
Human Services, Colorado Department
of Public Health and Environment,
Johns Hopkins University, the
University of Pennsylvania, and the
University of North Carolina at Chapel
Hill. CDC National Center on Birth
Defects and Developmental Disabilities
will participate as the 6th site. The
multi-site, collaborative study will be an
epidemiological investigation of

possible causes for the autism spectrum
disorders.
Study participants will be selected
from children born in and residing in
the following six areas: Atlanta
metropolitan area, San Francisco Bay
area, Denver metropolitan area,
Baltimore metropolitan area,
Philadelphia metropolitan area, and
Central North Carolina. Children with
autism spectrum disorders will be
compared to children with other
developmental problems, referred to as
the neurodevelopmentally impaired
group (NIC), as well as children who do
not have developmental problems,
referred to as the subcohort.
Data collection methods will consist
of the following: (1) Medical record
review of the child participant; (2)
medical record review of the biological
mother of the child participant; (3) a
packet sent to the participants with selfadministered questionnaires and a
buccal swab kit; (4) a telephone
interview focusing on pregnancy-related
events and early life history (biological
mother and/or primary caregiver
interview); (5) a child development
evaluation (more comprehensive for
case participants than for the control
group participants); (6) parent-child
development interview (for case
participants only) administered over the
telephone or in-person; (7) a physical
exam of the child participant; (8)
biological sampling of the child
participant (blood and hair); and (9)
biological sampling of the biological
parents of the child participant (blood
only). There is no cost to respondents
other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS

1.
2.
3.
4.
5.

mstockstill on PROD1PC61 with NOTICES

Number of
responses per
respondent

Number of
respondents

Form

Avg. burden per
response
(in hours)

Total burden
hours

Initial Contact by Mail ..................................................................
Invitation Telephone Contact .......................................................
Self-administered Questionnaires and buccal sample ................
Caregiver Interview by telephone ................................................
Child Clinic Visit (Child Development Evaluation, physical
exam, and biosamples) ................................................................
Case .........................................................................................
NIC ............................................................................................
Subcohort .................................................................................
6. Parent-Child Development Interview (Case participants only) ....
7. Parent biosamples .......................................................................

17,610
8,922
3,456
3,282

1
1
1
1

0.17
0.33
3.17
0.83

2,994
2,944
10,955
2,724

3,114
810
1,170
1,134
810
3,114

1
1
1
1
1

2.0
1.33
1.33
3.17
0.25

1,620
1,556
1,508
2,568
779

Total ...................................................................................

............................

............................

............................

27,648

VerDate Aug<31>2005

15:42 Oct 04, 2006

Jkt 211001

PO 00000

Frm 00082

Fmt 4703

Sfmt 4703

E:\FR\FM\05OCN1.SGM

05OCN1

58866

Federal Register / Vol. 71, No. 193 / Thursday, October 5, 2006 / Notices

Dated: September 29, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–16455 Filed 10–4–06; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
September 18, 2008.
For information contact Elaine L.
Baker, Designated Federal Officer,
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Management
Analysis and Services Office, 1600
Clifton Road, NE., Mailstop E72,
Atlanta, Georgia 30333, telephone 404–
498–0090 or fax 404–498–0011.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: September 25, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–16464 Filed 10–4–06; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

mstockstill on PROD1PC61 with NOTICES

Centers for Disease Control and
Prevention
Discontinued Publication of Funding
Opportunity Announcements
The Centers for Disease Control
and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of New Procedure.
AGENCY:

VerDate Aug<31>2005

15:42 Oct 04, 2006

Jkt 211001

Important notice regarding: (1)
Discontinued publication of Funding
Opportunity Announcements (FOAs) in
the Federal Register; and (2) FOA
announcement and application
submission via Grants.gov. CDC
announces plans to publish all FOAs on
http://www.grants.gov and accept
electronic applications through this site.
All application packages will be posted
on Grants.gov, as well, utilizing the
PHS5161–1 forms for non-research
applications and the new form SF 424
Research and Related (R&R) application
for research. Grants.gov will feed the
form 424 (R&R) packages directly into
the Health and Human Services
electronic Research Administration
Commons for on-line receipt of research
applications.
As of October 1, 2005, CDC ceased
publication of all FOAs in The Federal
Register. CDC currently announces
these FOAs, also known as Requests for
Application (RFAs) and Program
Announcements (PAs), via the
Grants.gov on-line submission system.
Applicants are able to find a synopsis
and attachments of the complete text of
all CDC grants and cooperative
agreements, as well as apply
electronically for opportunities, via
http://www.Grants.gov. All FOAs will
continue to be posted on the CDC Web
site (http://www.cdc.gov/od/pgo/
funding/FOAs.htm) and on the NIH
Guide (http://grants1.nih.gov/grants/
guide/index.html), for research.
The provisions of the Federal
Financial Assistance Management
Improvement Act of 1999 (Public Law
106–107) and the President’s
Management Agenda have led Federal
Agencies to simplify Federal financial
assistance application requirements and
create a single Web site to apply for
Federal assistance. Accordingly,
Grants.gov (http://www.grants.gov/) has
been designated by the Office of
Management and Budget (OMB) as the
single access point for all grant
programs offered by 26 Federal grantmaking agencies. It provides a single
interface for agencies to announce their
grant opportunities, and for all grant
applicants to find and apply for these
opportunities.
The PHS–5161–1 application package
will be posted in Grants.gov for CDC
non-research application submissions.
A transition from the PHS Form 398
package to the SF 424 (R&R) forms will
allow electronic submission of research
applications through Grants.gov.
Getting Started—Grants.gov and HHS
eRA Commons Registration
To provide a secure environment, the
submission of electronic applications to

PO 00000

Frm 00083

Fmt 4703

Sfmt 4703

HHS and CDC will require organizations
to register with Grants.gov (http://
www.grants.gov/applicants/
applicants.jsp), and, in addition, for
Research Grants, the applicant will also
have to register with HHS eRA
Commons (https://
commons.era.nih.gov/commons/).
Grants.gov registration provides the
ability to submit applications
electronically to at least 26 Federal
grant-making agencies. HHS eRA
Commons registration allows tracking of
research application status for the
potential grantee organization and
Principal Investigator.
Additional Information
Questions regarding this notice
should be directed to the Technical
Information Management Section
(TIMS), Procurement and Grants Office,
Centers for Disease Control and
Prevention, 2920 Brandywine Road,
Atlanta, GA 30341, Telephone 770–488–
2700, or e-mail address:
[email protected].
Dated: September 26, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–16322 Filed 10–4–06; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Request for Nominations for
Nonvoting Members Representing
Industry Interests on Public Advisory
Panels or Committees
AGENCY:

Food and Drug Administration,

HHS.
ACTION:

Notice.

SUMMARY: The Food and Drug
Administration (FDA) is requesting
nominations for nonvoting industry
representatives to serve on the National
Mammography Quality Assurance
Advisory Committee (NMQAAC) and
certain device panels of the Medical
Devices Advisory Committee in the
Center for Devices and Radiological
Health.
DATES: Industry organizations interested
in participating in the selection of a
nonvoting member to represent industry
for the vacancies listed in this document
must send a letter to FDA by November
6, 2006, stating their interest in the
NMQAAC or one or more panels.
Concurrently, nomination materials for
prospective candidates should be sent to
FDA by November 6, 2006. A nominee

E:\FR\FM\05OCN1.SGM

05OCN1